Vimarsana
Biggest News Aggregation in the World

Page 2 - Primary Focus News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Primary Focus. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Primary Focus Today - Breaking & Trending Today

Global Industrial Brakes and Clutches Industry Report 2023-2030: Wider Use Case across Numerous Application Domains - Vimarsana News

Global Industrial Brakes and Clutches Industry Report 2023-2030: Wider Use Case across Numerous Application Domains

/PRNewswire/ -- The "Industrial Brakes and Clutches - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering. Global...

China's National Medical Products Administration Accepts Astellas' Biologics License Application for Zolbetuximab - Astellas Pharma (OTC:ALPMY) - Vimarsana News

China's National Medical Products Administration Accepts Astellas' Biologics License Application for Zolbetuximab - Astellas Pharma (OTC:ALPMY)

TOKYO, July 31, 2023 /PRNewswire/ -- Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") today announced that the Center for Drug Evaluation (CDE) of the China National Medical Products

China's National Medical Products Administration Accepts Astellas' Biologics License Application for Zolbetuximab - Vimarsana News

China's National Medical Products Administration Accepts Astellas' Biologics License Application for Zolbetuximab

/PRNewswire/ -- Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") today announced that the Center for Drug Evaluation (CDE) of the...

EU Probes Microsoft's Teams-Office Bundle for Antitrust Violations - Vimarsana News

EU Probes Microsoft's Teams-Office Bundle for Antitrust Violations

Microsoft has come under the scanner for its "unjust" bundling of Microsoft Teams with other apps, raising anti-competitive concerns.

European Medicines Agency Accepts Astellas' Marketing Authorization Application for Zolbetuximab - Vimarsana News

European Medicines Agency Accepts Astellas' Marketing Authorization Application for Zolbetuximab

/PRNewswire/ -- Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") today announced the European Medicines Agency (EMA) has accepted...